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Roles for common MLL/COMPASS subunits and
the 19S proteasome in regulating CIITA pIV and
MHC class II gene expression and promoter
methylation
Olivia I Koues1, Ninad T Mehta2, Agnieszka D Truax2, R Kyle Dudley3, Jeanne K Brooks2, Susanna F Greer2*
Abstract
Background: Studies indicate that the 19S proteasome contributes to chromatin reorganization, independent of
the role the proteasome plays in protein degradation. We have previously shown that components of the 19S
proteasome are crucial for regulating inducible histone activation events in mammalian cells. The 19S ATPase Sug1
binds to histone-remodeling enzymes, and in the absence of Sug1, a subset of activating epigenetic modifications
including histone H3 acetylation, H3 lysine 4 trimethylation and H3 arginine 17 dimethylation are inhibited at
cytokine-inducible major histocompatibilty complex (MHC)-II and class II transactivator (CIITA) promoters,
implicating Sug1 in events required to initiate mammalian transcription.
Results: Our previous studies indicate that H3 lysine 4 trimethylation at cytokine-inducible MHC-II and CIITA
promoters is dependent on proteolytic-independent functions of 19S ATPases. In this report, we show that
multiple common subunits of the mixed lineage leukemia (MLL)/complex of proteins associated with Set I
(COMPASS) complexes bind to the inducible MHC-II and CIITA promoters; that overexpressing a single common
MLL/COMPASS subunit significantly enhances promoter activity and MHC-II HLA-DRA expression; and that these
common subunits are important for H3 lysine 4 trimethylation at MHC-II and CIITA promoters. In addition, we
show that H3 lysine 27 trimethylation, which is inversely correlated with H3 lysine 4 trimethylation, is significantly
elevated in the presence of diminished 19S ATPase Sug1.
Conclusion: Taken together, these experiments suggest that the 19S proteasome plays a crucial role in the initial
reorganization of events enabling the relaxation of the repressive chromatin structure surrounding inducible
promoters.
Background
Di- or trimethylation (hypermethylation) of histone H3
at lysine 4 (H3K4) is found at actively transcribed genes
[1-5], is functionally linked to activating acetylation
events at promoters [6], and is mediated by the mixed
lineage leukemia (MLL)/complex of proteins associated
with Set I (COMPASS)-like complexes [7,8]. MLL/
COMPASS-like complexes contain several well-charac-
terized, common subunits; Ash2L, WDR5 and RbBP5,
which are conserved between yeast and humans [9-11].
These subunits are thought to constitute a common
MLL/COMPASS subcomplex that forms a platform to
mediate the Set1 enzyme and H3K4 substrate interac-
tion [9,11-13]. H3K4 hypermethylation also has been
found to inhibit H3K9 methylation, and more recently
has been associated with a release from repressive
H3K27 methylation by MLL/COMPASS-associated his-
tone demethylases [14-19]. Observations that the
deposition of activating methylation events on H3K4
correlates with the removal of silencing methylation
events on H3K27 have important implications for the
regulation of bivalent genes, including cytokine-induci-
ble genes of the immune system.* Correspondence: sgreer@gsu.edu2Division of Cellular and Molecular Biology and Physiology, Georgia State
University, Atlanta, Georgia, USA
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Major histocompatibility class (MHC)-II molecules are
cell surface glycoproteins that present antigenic peptides
to CD4+ T lymphocytes of the adaptive immune system
[20,21]. MHC-II expression is regulated primarily at the
level of transcription by several well-studied elements
within the MHC-II proximal promoter, which bind a
series of ubiquitously expressed transcription factors to
form a basal enhanceosome complex (see Additional file
1) [22-24]. Once assembled, the enhanceosome recruits
a master regulator, the class II transactivator (CIITA)
[25]. Transcription of CIITA is driven by one of four
distinct promoters in a cell-type and cytokine specific
manner. The well-characterized CIITA promoter (p)IV
is responsible for interferon (IFN)-g-inducible expression
in nucleated cells [26,27]. Upon cytokine stimulation,
the Janus kinase/signal transducer and activator of tran-
scription 1 (JAK/STAT) pathway is triggered, leading to
pIV accumulation of the requisite transcription factors,
and the initiation of CIITA transcription [28-30]. Once
recruited to the MHC-II promoter, CIITA binding stabi-
lizes the enhanceosome complex and recruits basal tran-
scriptional components to initiate the switch to an
elongation complex [24,31-34]. Although much is
known about the requirement of transcription factors at
these cytokine-inducible promoters, considerably less is
understood about the coordination of the histone modi-
fying events that allow these promoters to switch from a
semi-poised state to a fully open, transcription-accessi-
ble structure.
The objective of this study was to investigate the
importance of 19S ATPase-regulated activating histone
H3 trimethylation at lysine 4 (H3K4me3) events in chro-
matin remodeling at MHC-II and CIITA promoters, and
to determine if the 19S ATPase Sug1directly affects
multiple promoter remodeling events. In this report, we
show that common MLL/COMPASS subunits (Ash2L,
RbBP5 and WDR5) bind to the MHC-II promoter and
to CIITA pIV; that overexpressing a single common
subunit significantly enhances promoter activity and
MHC-II HLA-DRA expression; and that WDR5 knock-
down decreases H3K4me3 at promoters of both MHC-
II and CIITA. Although we have previously shown
H3K18 acetylation to be regulated by 19S ATPases,
there were no observable changes in levels of H3K18
acetylation in the absence of WDR5, indicating that
Sug1 independently regulates acetylation and methyla-
tion events. Further supporting our hypothesis that Sug1
regulates multiple independent events is our observation
that knockdown of Sug1 promotes elevated H3K27me3
levels at cytokine-inducible promoters. Together these
results implicate the 19S proteasome in the initial reor-
ganization of chromatin to relax the repressive histone
environment surrounding cytokine-inducible promoters.
Results
Common MLL/COMPASS subunits associate with
cytokine-inducible promoters
H3K4me3 is mediated by histone methyltransferase
(HMTase) enzymes, which are typically recruited to
DNA as part of a larger complex of proteins MLL/
COMPASS [7,8,10,35]. We previously showed that the
19S ATPase Sug1 positively regulates H3K4me3 at the
MHC-II proximal promoter and at CIITA pIV, poten-
tially by stabilizing the association of common MLL/
COMPASS subunits [36]. We observed that the com-
mon MLL/COMPASS subunit WDR5 binds to CIITA
pIV with a moderate enhancement in recruitment
observed upon cytokine stimulation, which is lost upon
Sug1 knockdown [36]. To expand on the potential for
MLL/COMPASS binding to CIITA pIV, we performed
chromatin immunoprecipitation (ChIP) assays to deter-
mine if additional common MLL/COMPASS subunits
also bind to CIITA pIV (Figure 1a-c). WDR5 (Figure
1a), Ash2L (Figure 1b) and RbBP5 (Figure 1c) associate
with CIITA pIV in unstimulated cells, and levels of
association are moderately enhanced upon prolonged
cytokine stimulation. To determine if these common
MLL/COMPASS subunits are recruited to the MHC-II
proximal promoter, similar ChIP assays were performed
(Figure 1d-f). Each of the three subunits, WDR5 (Figure
1d), Ash2L (Figure 1e) and RbBP5 (Figure 1f), bound to
the MHC-II promoter in both unstimulated and stimu-
lated cells, suggesting that these common subunits of
MLL/COMPASS complexes form a backbone complex
to allow H3K4me3 at these cytokine-inducible genes. It
is noteworthy that these common MLL/COMPASS sub-
units are significantly associated with these cytokine-
inducible promoters in unstimulated cells, as elevated
levels of H3K4me3 have been reported previously
[36-40] to accumulate only upon prolonged stimulation
with IFN g. All three of these subunits also bound to
the constitutively expressed GAPDH promoter (see
Additional file 2).
Overexpressing a single common subunit of MLL/
COMPASS complexes enhances CIITA transactivity and
MHC-II HLA-DRA expression
To characterize the effect these common subunits of
MLL/COMPASS have on the MHC-II proximal promo-
ter, we performed luciferase reporter assays in unstimu-
lated HeLa cells, in which the MHC-II HLA-DRA
promoter is fused to a luciferase gene and is expressed
along with CIITA and common MLL/COMPASS subu-
nits WDR5 (Figure 2a), Ash2L (Figure 2b) or RbBP5
(Figure 2c). In cells transfected with CIITA alone, there
was a 15-20-fold increase in HLA-DRA promoter activity
(Figure 2a-c, gray bars), whereas overexpressing a single
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common MLL/COMPASS subunit (Figure 2a-c, white
bars) significantly enhanced the ability of CIITA to drive
the HLA-DRA promoter. Similarly, overexpressing a sin-
gle common MLL/COMPASS subunit dramatically
enhanced MHC-II HLA-DRA (Figure 2d) and GAPDH
transcript levels (Figure 2e).
A WDR5-dependent complex trimethylates H3K4 at
cytokine-inducible genes
We observed that various common MLL/COMPASS
subunits are recruited to both the MHC-II proximal
promoter and to CIITA pIV (Figure 1), and that overex-
pressing these subunits can drive CIITA-dependent
MHC-II gene expression (Figure 2). As these subunits
are thought to constitute a common MLL/COMPASS
subcomplex [9,11-13], we employed RNA interference
to determine the contribution of WDR5 to the trimethy-
lation of histone H3 lysine 4 at these genes. ChIP assays
were performed in HeLa cells transfected with small
interfering (si)RNA specific for the common MLL/
COMPASS subunit WDR5 (Figure 3). Knockdown of
WDR5 resulted in a significant loss in both basal and
inducible H3K4me3 at the MHC-II proximal promoter
(Figure 3b), at CIITA pIV (Figure 3c) and at the
GAPDH promoter (see Additional file 3).
WDR5 does not contribute to histone H3K18 acetylation
The ATPases of the 19S regulator, which serves as the
cap of the 26S proteasome, have been implicated in
mediating a subset (H3K18ac, H3R17me2 and
H3K4me3) of histone-activating modifications, indepen-
dent of the canonical protein degradation role of the
proteasome [36,41]. We have previously observed that
WDR5 associates with histone-modifying enzymes
known to mediate this subset of activating modifications
including cAMP response element binding protein
(CBP), coactivator-associated arginine methyltransferase
(CARM)1 [36,41] and the HMTase SET1 [10,35]. To
characterize the role of WDR5 in mediating additional
histone modifications, we performed ChIP in cells trans-
fected with WDR5 siRNA (Figure 4). Because CBP is
capable of mediating H3K18ac [42,43], we determined
by ChIP assay the levels of H3K18ac at the MHC-II
proximal promoter (Figure 4a) and CIITA pIV (Figure
4b) in WDR5 knockdown cells. Levels of H3K18 acetyla-
tion in WDR5 knockdown cells (Figure 4a-b, white bars)
Figure 1 Common MLL/COMPASS subunits associate with cytokine-inducible genes. (a-c) Several common subunits of MLL/COMPASS
associate with CIITA pIV. ChIP assays were carried out in HeLa cells stimulated with IFN-g for 0 to 18 hours. Lysates were immunoprecipitated
with control or endogenous (a) WDR5, (b) Ash2L or (c) RbBP5 antibody. Associated DNA was isolated and analyzed via real-time PCR using
primers and probe spanning CIITA pIV. (d-f) Subunits of MLL/COMPASS associate with the MHC-II proximal promoter. ChIP assays were carried
out in HeLa cells stimulated with IFN-g for 0 to 18 hours. Lysates were immunoprecipitated with control or endogenous (d) WDR5, (e) Ash2L or
(f) RbBP5 antibody. Associated DNA was isolated and analyzed via real-time PCR using primers and probe spanning the MHC-II proximal
promoter. To demonstrate constitutive binding, data are presented as percentage input. IgG isotype control values were 0.001 ± 0.0005 (CIITA
pIV) and 0.01 ± 0.007 (MHC-II promoter). Values represent mean ± SEM of (n = 3) independent experiments.
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were comparable to those in control siRNA-transfected
cells (Figure 4a-b, black bars). WDR5 knockdown signif-
icantly decreased H3K4me3 but did not affect H3K18ac
at the GAPDH promoter (see Additional file 3). As pre-
viously shown [36,41], neither cytokine stimulation nor
siRNA transfection results in a loss of endogenous his-
tone H3 (see Additional file 4). Therefore, although we
had previously observed interaction of WDR5 with the
HAT CBP, which is responsible for H3K18ac, and
although both WDR5 and CBP binding are negatively
affected by knockdown of the 19S ATPase Sug1, knock-
down of WDR5 did not have a similar effect to that of
Sug1 knockdown on CBP, as there was no effect on his-
tone H3K18 acetylation. Thus, we looked further up the
activation sequence to determine the role played by
Sug1 in activating cytokine-inducible genes.
H3K27me3 is enhanced upon Sug1 knockdown
Evidence suggests that demethylation of silencing modi-
fications is intimately linked to the deposition of his-
tone-activating events to promote the relaxation of the
repressive nature of chromatin. The recently identified
H3K27me3 histone demethylase human UTX (ubiqui-
tously transcribed tetratricopeptide repeat gene on X
Figure 2 Overexpressing a single common subunit of MLL/COMPASS complexes enhances CIITA transactivity. (A-C) Overexpression of
common MLL/COMPASS subunits increases CIITA transactivity at the MHC-II promoter. HeLa cells were transfected with HLA-DRA-Luc, Renilla,
pcDNA3, CIITA and (a) WDR5, (b) Ash2L or (c) RbBP5. Luciferase activity is reported as fold activation relative to that of the reporter alone.
Luciferase readings were normalized to Renilla activity. Assays were performed in triplicate and values represent mean ± SEM of (n = 3)
independent experiments. (d-e) Overexpression of common MLL/COMPASS subunits increases MHC-II transcript levels. HeLa cells were either left
untransfected or were transfected with CIITA alone or in combination with WDR5, Ash2L or RbBP5. RNA was prepared using TRIzol reagent and
cDNA was generated using gene specific antisense primers for (d) MHC-II HLA-DR and (e) GAPDH. cDNA was quantified via real-time PCR, and
data are graphed as fold changes over non-transfected samples. Values represent mean ± SEM of (n = 2) independent experiments. *P < 0.05 vs
control siRNA.
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chromosome), a member of the Jumonji C family of
proteins, is a di- and trimethyl H3K27 demethylase,
which has been found in complex with common MLL/
COMPASS subunits and associated with the elongating
form of RNA polymerase II [14,15,44]. To determine if
UTX associates with cytokine-inducible promoters,
ChIP assays were performed for endogenous UTX
recruitment to the inducible CIITA pIV (Figure 5a) and
the MHC-II proximal promoter (Figure 5b). Low levels
of UTX are bound to CIITA pIV in unstimulated cells
(Figure 5a), which corresponds to elevated H3K27me3
in unstimulated cells (Figure 5d). Rapid recruitment of
UTX to CIITA pIV is observed upon cytokine stimula-
tion (Figure 5a), which correlates with reports of early
chromatin remodeling events and rapid transcription
factor recruitment to CIITA pIV [28,37,45].
Figure 3 Knockdown of a common MLL/COMPASS subunit decreases H3K4me3. (a) WDR5 knockdown efficiently reduces WDR5 expression.
HeLa cells were transfected with control or WDR5-specific siRNA, harvested and subjected to western blot analysis for (top) endogenous WDR5
and (bottom) endogenous tubulin. (b-c) WDR5 knockdown decreases H3K4me3. HeLa cells transfected with scrambled control or WDR5-specific
siRNA were stimulated with IFN-g and subjected to ChIP assay. Lysates were immunoprecipitated with control or endogenous H3K4me3
antibody. Associated DNA was isolated and analyzed via real-time PCR as described in Figure 1, using primers and probes specific for (b) the
MHC-II promoter or (c) CIITA pIV. Data are presented as percentage input. IgG Isotype control values were 0.06 ± 0.03 (MHC-II promoter) and
0.003 ± 0.002 (CIITA pIV). Values represent mean ± SEM of (n = 3) independent experiments. *P < 0.05 vs control siRNA.
Figure 4 WDR5 knockdown does not affect H3K18ac. (a, b) HeLa cells transfected with scrambled control or WDR5-specific siRNA were
stimulated with IFN-g and subjected to ChIP assay. Lysates were immunoprecipitated with control or endogenous H3K18ac antibody. Associated
DNA was isolated and analyzed via real-time PCR as described in Figure 2, using primers and probes specific for (a) MHC-II promoter or (b) CIITA
pIV. Data are presented as percentage input. IgG Isotype control values were 0.06 ± 0.03 (MHC-II promoter) and 0.003 ± 0.002 (CIITA pIV). Values
represent mean ± SEM of (n = 3) independent experiments.
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Additionally, recruitment of UTX to the MHC-II pro-
moter (Figure 5b) correlates with a reduction in
H3K27me3 levels (Figure 5e). By contrast, UTX associa-
tion remains relatively constant over a time course of
IFN-g at the constitutively active GAPDH promoter
(Figure 5c), where levels of H3K27me3 are low (Figure
5f).
We previously observed that Sug1 regulates H3K18ac,
H3R17me2 and H3K4me3 modifications independently
from other localized enzymes [36]. These data suggested
that the 19S proteasome may play a role in regulating
multienzyme recruitment to cytokine-inducible promo-
ters, but does not eliminate the possibility that 19S
ATPases may regulate an additional upstream event that
is a prerequisite for these events. Therefore, we sought
to determine the degree of H3K27me3 in Sug1 knock-
down cells. Chromatin immunoprecipitations in HeLa
cells transfected with Sug1 siRNA (Figure 6b-c, white
bars) show that H3K27me3 levels are substantially ele-
vated over similarly treated control siRNA transfected
cells (Figure 6b-c, black bars). At the non-bivalent
GAPDH promoter, the lack of Sug1 fails to significantly
affect H3K27me3 (Figure 6d). Together these data
strongly suggest that the lack of Sug1 promotes a closed
chromatin structure.
Discussion
We previously demonstrated that the 19S proteasome
regulates activating H3K4 trimethylation at cytokine-
inducible promoters, potentially through interactions
Figure 5 UTX recruitment correlates with a reduction in H3K27 trimethylation. (a-c) UTX associates with cytokine-inducible promoters.
ChIP assays were carried out in HeLa cells stimulated with IFN-g for 0 to 18 hours. Lysates were immunoprecipitated with control or
endogenous UTX antibody. Associated DNA was isolated and analyzed via real-time PCR, using primers and probe spanning (a) CIITA pIV, (b) the
MHC-II promoter or (c) the GAPDH promoter. Data are presented as percentage input. Values represent mean ± SEM of (n = 3) independent
experiments. (d-f) H3K27 trimethylation was lost upon cytokine stimulation. ChIP assays were carried out in HeLa cells stimulated with IFN-g for
0 to 18 hours. Lysates were immunoprecipitated with control or endogenous H3K27me3 antibody. Associated DNA was isolated and analyzed
via real-time PCR using primers and probe spanning (d) CIITA pIV, (e) the MHC-II promoter or (f) the GAPDH promoter. Data are presented as
percentage input. IgG isotype control values were 0.001 ± 0.0002 (CIITA pIV), 0.08 ± 0.02 (MHC-II promoter) and 0.001 ± 0.0009 (GAPDH
promoter). Values represent mean ± SEM of (n = 3) independent experiments.
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with common MLL/COMPASS subunits, as a loss of
recruitment of WDR5 and Ash2L subunits is observed
upon Sug1 knockdown [36]. In the current study, we
showed that these common MLL/COMPASS subunits
including WDR5, Ash2L and RbBP5 bind to both the
MHC-II promoter and to CIITA pIV. The enrichment
of recruited subunits upon IFN-g stimulation varies, and
the subunits bind with intensities similar to constitu-
tively expressed GAPDH. Whether the increases in
recruitment of these common subunits reflects increases
in binding or differences in antibody affinity remains to
be determined. One plausible explanation is that a sub-
complex is assembled on promoters before transcription
initiation. Overexpressing a single common MLL/COM-
PASS subunit significantly enhances promoter activity
and gene expression, further implicating these subunits
as co-activators for MHC-II. Consistent with this, we
observed a loss of H3K4me3 at the MHC-II promoter
and CIITA pIV when levels of endogenous WDR5 were
diminished. However, as WDR5 has been found in com-
plexes that lack SET domain histone methyltransferase
enzymes, we cannot rule out the possibility that the loss
of H3K4me3 observed upon WDR5 knockdown is due
to other mechanisms [46].
We previously observed a loss in inducible WDR5 and
Ash2L binding to CIITA pIV when endogenous Sug1 is
diminished [36]. These findings implied that the 19S
proteasome plays a role in stabilizing a large multien-
zyme histone remodeling complex through an interac-
tion dependent on WDR5 at cytokine-inducible genes.
Therefore, we sought to determine if knockdown of
WDR5 mirrors that of 19S ATPase knockdown, which
results in a loss of H3K18ac in addition to H3K4me3
[36,41,45]. Knockdown of WDR5 did not mirror that of
Sug1 knockdown as there was no effect on histone
H3K18 acetylation. Thus, the initial chromatin reorgani-
zation event regulated by 19S ATPases remains to be
determined.
Evidence now suggests that demethylation of silencing
modifications is intimately linked to the deposition of
histone-activating events to promote the relaxation of
the repressive nature of chromatin [14,15,47,48]. In
addition to binding CBP and CARM-1, the common
MLL/COMPASS subunit WDR5 is associated with his-
tone H3K27me3 demethylases [14,15]. Consistent with
this, we observed a gain of one of the known
H3K27me3 demethylases (UTX) and a loss of
H3K27me3 at CIITA pIV, and at the MHC-II promoter,
upon cytokine induction [14]. As we previously observed
that WDR5 and Ash2L binding to CIITA pIV is inhib-
ited in the absence of Sug1, it was expected that histone
demethylase recruitment would be negatively affected
upon diminished Sug1 expression and would in turn
affect regulation of H3K27me3. In fact, H3K27me3
Figure 6 H3K27me3 is enhanced upon Sug1 knockdown. (a)
Sug1 siRNA efficiently decreases endogenous Sug1. HeLa cells were
transfected with control or Sug1-specific siRNA, harvested and
subjected to western blot analysis for (top) endogenous Sug1 and
(bottom) endogenous tubulin. (b-d) H3K27me3 is elevated at
cytokine-inducible genes upon diminished Sug1 expression. ChIP
assays were carried out in HeLa cells stimulated with IFN-g for 0 to
18 hours. Lysates were immunoprecipitated with control or
endogenous H3K27me3 antibody. Associated DNA was isolated and
analyzed as in Figure 2 using primers and probe spanning (b) CIITA
pIV, (c) the MHC-II proximal promoter and (d) the GAPDH promoter.
Data are presented as percentage input. IgG isotype control values
were 0.003 ± 0.001 (CIITA pIV), 0.08 ± 0.02 (MHC-II promoter) and
0.01 ± 0.005 (GAPDH promoter). Values represent mean ± SEM of (n
= 3) independent experiments.
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levels are significantly elevated at each of these cytokine-
inducible, bivalent promoters in Sug1 siRNA-transfected
cells, but are unaffected at the constitutively active
GAPDH promoter. As little is known regarding how
inducible genes are relieved from and subsequently
returned to a repressive state, the dynamic recruitment
and activity of UTX and other histone H3K27me3
demethylases to cytokine-inducible promoters is not
well understood. Although we show here that the 19S
ATPase Sug1 functions to release chromatin from a
repressive state, further studies are required to charac-
terize the molecular interactions between 19S ATPases,
UTX, JMJD3 and silenced chromatin.
To our knowledge, ours is the first report implicating
the 19S proteasomal ATPases in regulating the initial
chromatin remodeling events at cytokine-inducible pro-
moters that releases surrounding chromatin from a
more condensed, repressive state. Our observations that
in the absence of Sug1, methylation of H3K27 is not
only elevated, but is also persistent, strongly implicate
the 19S ATPases in initial chromatin reorganization in
response to stimuli. A full understanding of the contri-
butions of Sug1 and the other 19S ATPases to the initial
epigenetic regulation and chromatin reorganization at
cytokine-inducible genes requires further studies into
the molecular interactions occurring at these promoters.
Methods
Cell Lines
HeLa (human epithelial) cells (American Type Culture
Collection, Manassas, VA, USA) were maintained in
Dulbecco’s modified Eagle’s medium (DMEM; Media-
tech Inc., Herndon, VA, USA) supplemented with 10%
fetal calf serum, 5 mM L-glutamine and 5 mM penicil-
lin-streptomycin at 37°C with 5% carbon dioxide.
Antibodies
Trimethylated H3K4, acetylated H3K18 and WDR5 anti-
bodies were from Abcam (Cambridge, MA, USA).
Ash2L and RbBP5 antibodies were from Bethyl Labora-
tories (Montgomery, TX, USA). Rabbit IgG isotype con-
trol and mouse IgG isotype control antibodies were
from Upstate (Lake Placid, NY, USA). Sug1 antibody
was from Novus Biologicals (Littleton, CO, USA).
Horseradish peroxidase (HRP)-conjugated mouse anti-
body (W4021) was from Promega (Madison, WI, USA)
and HRP-conjugated rabbit antibody (1858415) was
from Pierce (Rockland, IL, USA).
Plasmids
Flag-CIITA, HLA-DRA-Luc, pcDNA3 plasmids were as
previously described [49]. Renilla luciferase control vec-
tor (E2231) was from Promega (Madison, WI, USA).
Myc-Sug1 was generously provided by A. A. Wani [50].
Flag-WDR5, Flag-Ash2L and Flag-RbBP5 were gra-
ciously provided by A. Shilatifard [35].
siRNA constructs and transient transfections
Previously described siRNAs [41,49] were used for tran-
sient knockdown of the Sug1 19S ATPase. Pooled
siRNA duplexes for WDR5 were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). HeLa cells
transfected with Allstar scrambled sequence control
siRNA (Qiagen, Valencia, CA, USA) or specific siRNA
were treated with IFN-g as indicated. Cells were lysed in
NP40 lysis buffer (1 M Tris pH 8.0, 1 M KCl, 10%
NP40, 0.5 M EDTA, 5 M NaCl, 1 M dithiothreitol, dis-
tilled (d)H2O) supplemented with Complete EDTA-free
Protease Inhibitors (Roche, Indianapolis, IN, USA), and
knockdown efficiency was assessed by immunoblotting
as described above.
Luciferase reporter assays
HeLa cells plated in six-well plates at a density of 5 ×
104 cells/well were transfected with CIITA, HLA-DRA-
Luc, Renilla, pcDNA3 and MLL/COMPASS subunit
plasmids as indicated, using Fugene 6 (Roche) according
to the manufacturer’s instructions. Twenty-four hours
after transfection, cells were subjected to dual-luciferase
assay (Promega) according to the manufacturer’s
protocol.
RNA transcript levels
HeLa cells were plated at a density of 8 × 105 cells/plate
and transfected with 1 μg CIITA alone or in combina-
tion with MLL/COMPASS subunit plasmids (0.5 μg and
1 μg) as indicated, using Fugene 6 (Roche) according to
the manufacturer’s instructions. Twenty-four hours after
transfection, cells were harvested and total RNA was
prepared using TRIzol reagent (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions.
Omniscript reverse transcription kit (Qiagen) was used
to generate cDNA using gene-specific antisense primers
for MHC-II HLA-DR [49] and GAPDH [51]. cDNA was
quantified via real-time PCR using previously published
primers and probes specific for MHC-II HLA-DR [49]
and GAPDH [51]. Real-time PCR values were generated
on the basis of standard curves generated for each gene
and are presented as fold changes over non-transfected
samples.
ChIP assays
ChIP assays were performed as previously described
[52]. In brief, HeLa cells were stimulated with 500 U/ml
IFN-g (Peprotech, Rocky Hill, NJ, USA) as indicated.
Crosslinked cells were lysed in SDS lysis buffer (1%
SDS, 10 mM EDTA, 50 mM Tris pH 8.0, dH20) with
Complete EDTA-free Protease Inhibitors (Roche) for 20
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minutes on ice, and sonicated to generate sheared DNA
with an average length of 500-750 bp. Sonicated samples
were precleared with salmon sperm-coated agarose
beads (Upstate), and half of the lysate was immunopre-
cipitated with 5 μg of polyclonal antibody against
H3K4me3, H3K18ac, WDR5 (all Abcam), Ash2L or
RbBP5 (both Bethyl Laboratories) overnight at 4°C. The
remaining lysate was immunoprecipitated with isotype
control antibody (Upstate). After a 2 hour incubation
with 60 μl of salmon sperm-coated agarose beads, sam-
ples were washed for 5 minutes at 4°C with the follow-
ing buffers: low salt buffer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM Tris pH 8.0, 150 mM NaCl,
dH20), high salt buffer (0.1% SDS, 1% Triton X-100, 2
mM EDTA, 20 mM Tris pH 8.0, 500 mM NaCl, dH20),
LiCl buffer (0.25 M LiCl, 1% NP40, 1% DOC, 1 mM
EDTA, 10 mM Tris pH 8.0, dH20) and 1 × TE buffer,
and were eluted with SDS elution buffer (1% SDS, 0.1
M NaHCO3, dH2O). After elution, crosslinks were
reversed with 5 M NaCl at 65°C and immunoprecipi-
tated, and control DNA was isolated using a phenol:
chloroform:isoamyl alcohol mix (Invitrogen) according
to the manufacturer’s protocol. Isolated DNA was ana-
lyzed by real-time PCR using probes and primers span-
ning the W-X-Y box of the MHC-II HLA-DRA
promoter and CIITA pIV [36,41,49]. Values graphed
were calculated based on standard curves generated.
ChIP in siRNA knockdown cells
HeLa cells were transfected with specific siRNA or con-
trol siRNA using RNAiFect transfection reagent (all
from Qiagen) according to the manufacturer’s instruc-
tions. Cells were treated with 500 U/ml IFN-g as indi-
cated. 10% of the total cell volume was lysed in 1%
Nonidet P-40 buffer (1 M Tris pH 8.0, 1 M KCl, 10%
NP40, 0.5 M EDTA, 5 M NaCl, 1 M DTT, dH2O) with
Complete EDTA-free Protease Inhibitors (Roche) and
analyzed by immunoblotting for knockdown verification.
The remaining fraction of cells was subjected to ChIP
assay.
Additional file 1: Supplemental Figure 1. IFN-g inducible CIITA
promoter IV (pIV) transcription drives expression of MHC-II. Before IFN-g
stimulation, both MHC-II and CIITA pIV exhibit low to moderate
acetylation of histone H3 and H4 and are occupied by ubiquitiously
expressed factors. MHC-II is bound by an enhanceosome complex of
nuclear factor Y (NFY), regulatory factor X (RFX) and CREB, and pIV is
bound in a highly conserved E-box by upstream stimulating factor (USF)-
1 and c-Myc. Upon stimulation with the pro-inflammatory cytokine IFN-g,
the JAK/STAT1 pathway is triggered, leading to enhanced pIV acetylation
and methylation, to rapid recruitment of the STAT1 homodimer to the
pIV GAS element and to IFN response factors 1 and 2 (IRF1/2) binding to
the pIV IRE. Once expressed, CIITA binds each component of the
enhanceosome complex and recruits basal transcriptional components to
initiate the switch to an elongation complex.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1756-8935-3-5-
S1.PDF ]
Additional file 2: Supplemental Figure 2. Common MLL/COMPASS
subunits associate with the GAPDH promoter. (a-c) ChIP assays were
carried out in HeLa cells stimulated with IFN-g for 0 to 18 hours. Lysates
were immunoprecipitated with control or endogenous (a) WDR5, (b)
Ash2L or (c) RbBP5 antibody. Associated DNA was isolated and analyzed
via real-time PCR using primers and probe spanning the GAPDH
promoter. Data are presented as percentage input. Values represent
mean ± SEM of (n = 3) independent experiments. IgG isotype control
values were 0.001 ± 0.0005
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1756-8935-3-5-
S2.PDF ]
Additional file 3: Supplemental Figure 3. Knockdown of a common
MLL/COMPASS subunit decreases H3K4me3 but not H3K18ac at the
GAPDH promoter. (a, b) HeLa cells transfected with scrambled control or
WDR5-specific siRNA were stimulated with IFN-g and subjected to ChIP
assay. Lysates were immunoprecipitated with control, (a) endogenous
H3K4me3 or (b) endogenous H3K18ac antibody. Associated DNA was
isolated and analyzed via real-time PCR as described in Figure 1, using
primers and probes specific for the GAPDH promoter. Data are presented
as percentage input. IgG Isotype control values were 0.1 ± 0.05. Values
represent mean ± SEM of (n = 2-3) independent experiments.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1756-8935-3-5-
S3.PDF ]
Additional file 4: Supplemental Figure 4. Neither IFN-g stimulation nor
siRNA transfection affect levels of histone H3. (a, b) HeLa cells stimulated
with (a) IFN-g or (b) transfected with scrambled control or WDR5-specific
siRNA were subjected to ChIP assay. Lysates were immunoprecipitated
with control or endogenous H3 antibody. Associated DNA was isolated
and analyzed via real-time PCR as described in Figure 2 using primers
and probes specific for CIITA pIV. Data are presented as percentage
input. Values represent mean ± SEM of (n = 2-3) independent
experiments.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1756-8935-3-5-
S4.PDF ]
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